I am a Specialist Physician and Haematologist, and full-time academic at the University of Sydney Faculty of Medicine and Health, and a senior leader for HOCS for the Nepean Clinical School (NCS). I am recognised internationally for my P2X7 receptor and CLL research. Since promotion, I have raised my profile in fundamental and clinical research in the B cell receptor, inflammation, and dietary interventions for protection of non-cancer cells from damage by chemotherapy. I have published in high-ranking tier-1 journals for my specialty, including the FASEB Journal, the International Journal of Molecular Sciences, and Mayo Clinic Proceedings. My h-index is 28, and citations for my 52 publications (21 since my last promotion) now total 3,241 (April 2023). Since my last promotion, I have continued to attract competitive and philanthropic research funding totalling more than AUD1.5M as lead chief investigator and as part of research collaborations. Further, I have increased my lab personnel from one research assistant and two students (2014) to two research assistants, one postdoctoral fellow, one research fellow, two PhD and three MD research students. My international collaborations include groups at the University of East Anglia, UK; University of Ulm, Germany; University of Southern California; and University of Groningen, Netherlands.